Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Shares Outstanding (Diluted Average) (2022 - 2025)

Abeona Therapeutics (ABEO) has 6 years of Shares Outstanding (Diluted Average) data on record, last reported at $54.2 million in Q3 2025.

  • For Q3 2025, Shares Outstanding (Diluted Average) rose 40.87% year-over-year to $54.2 million; the TTM value through Sep 2025 reached $54.2 million, up 40.87%, while the annual FY2024 figure was $41.0 million, 91.99% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $54.2 million in Q3 2025 per ABEO's latest filing, down from $65.1 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $65.1 million in Q2 2025 and bottomed at $5.8 million in Q2 2022.
  • Average Shares Outstanding (Diluted Average) over 4 years is $29.3 million, with a median of $26.1 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Diluted Average): surged 312.61% in 2023, then surged 40.87% in 2025.
  • A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $7.9 million in 2022, then skyrocketed by 171.96% to $21.4 million in 2023, then surged by 91.99% to $41.0 million in 2024, then surged by 32.14% to $54.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $54.2 million in Q3 2025, $65.1 million in Q2 2025, and $49.8 million in Q1 2025.